LUNGevity Foundation Launches 2025 Lung Cancer Awareness Month with 60,000 White Flags on the National Mall in Washington DC“WASHINGTON, Nov. 3, 2025 /PRNewswire/ — This November, during Lung Cancer Awareness Month (LCAM), LUNGevity Foundation will lead a...
The New Lung Cancer Divide: Rural, Low-Income Young Adults Left Behind“A sweeping U.S. analysis of 18,595 people aged 18–50 diagnosed with early-onset non–small cell lung cancer (NSCLC) has a blunt message: outcomes hinge not only on tumor biology but on where you...
Personalized cancer vaccines: A new frontier in lung cancer treatment and prevention“Despite declining tobacco use, lung cancer remains the leading cause of cancer-related death worldwide. As oncologists seek more-effective and individualized therapies, Mayo Clinic...
Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics“ATNM-400 is...
FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer“Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase III IMforte study. First...
More News and Updates